千红制药(002550.SZ)：公司创新药项目QHRD106、QHRD107目前正处于有序推进临床研究的过程中

Core Viewpoint - QHRD106 and QHRD107, the innovative drug projects of Qianhong Pharmaceutical, are currently advancing in clinical research in an orderly manner [1] Group 1 - The company is actively engaged in the clinical research phase for its innovative drug projects [1]